discuss serena williams' glp-1 partnership Tennis legend Williams is making headlines after her Super Bowl ad promoting weight-loss medication went viral. The retired star revealed she lost around 14 kg with Zepbound through telehealth company Serena Williams is returning to

Weight loss isnt the goal

An analysis by the Annals of Internal Medicine published in October 2022 found that the price of GLP-1s would need to drop by 90% to be considered reasonable for use as a first-line therapy

Add fiber incrementally over several weeks to give your digestive system time to adjust, especially given that GLP-1 medications already affect gastric motility

Trimi correctly cites this as a 20% reduction in major heart events and appropriately attributes it to the SELECT trial and the specific FDA-approved Wegovy product and patient population

Diarrhoea associated with Saxenda is generally attributed to the drug's effects on gut motility and gastric emptying rather than bile acid malabsorption

BOC sciences provides high purity metabolites to help your innovative research